Helping marketers shape up for the job
April 2, 2007Business Services, Sales and Marketing PRIME, marketing, pm society, recruitment, training
Marketing is defined in the New English Dictionary as all the processes involved in moving goods from the producer to …
World news roundup
March 30, 2007Sales and Marketing
Crucell partners with ADImmune on flu vaccineDutch biotechnology company Crucell and Taiwanese-based ADImmune are to collaborate on an influenza vaccine …
US news roundup
March 30, 2007Sales and Marketing
Avicena starts phase III Parkinson's trialAvicena Group said that the National Institute of Neurological Disorders and Stroke (NINDS) has initiated …
Pfizer’s torcetrapib results cast doubt on CETP inhibitors
March 30, 2007Research and Development, Sales and Marketing Pfizer, lipid
New data on Pfizer's ill-fated torcetrapib suggest the drug doesn't reduce arterial plaque, casting doubt on other drugs in the …
Oxford BioMedica’s biotech buy adds to its cancer vaccine pipeline
March 29, 2007Sales and Marketing
Oxford BioMedica has expanded its product pipeline with the £16 million acquisition of fellow Oxford-based biotech Oxxon Therapeutics.The deal gives …
S-P and Merck to develop Lipitor combination
March 29, 2007Sales and Marketing cv
Schering-Plough and Merck have announced plans to develop a new 2-in-1 cholesterol pill that would include Lipitor, which belongs to …
Post-Northwick Park European guidelines out for consultation
March 26, 2007Research and Development phase I
European regulators have produced draft guidance for phase I research, designed to minimise the risk of a repeat of the …
Judicial review on Alzheimer’s drugs to go ahead
March 26, 2007Sales and Marketing
The decision to restrict access to Alzheimer's drugs for some patients is to be scrutinised in a UK court, it …
HIV market: collaborative combinations
March 26, 2007Research and Development, Sales and Marketing HIV, drug development, marketing
Two new HIV drugs, from Tibotec and Gilead, have been shown to be viable late-stage pipeline candidates. However, both TMC278 …
You have 6 new messages
March 26, 2007Medical Communications, Sales and Marketing e-marketing, marketing, marketing mix, new media
What are the biggest challenges in 2007 for e-marketing?Overexposure of e-detailing gave a poor response in many cases in 2006 …
Diabetes UK report criticises cutbacks in NHS
March 23, 2007diabetes
In a new report, Diabetes UK has criticised cutbacks in NHS diabetes treatment, suggesting that service reductions are putting patients' …
Eisai to buy biotech Morphotek
March 23, 2007Sales and Marketing Eisai, biotech
Eisai is to acquire Morphotek for $325 million, making it the latest pharma company to buy outright a biotech company …
AstraZeneca’s pipeline suffers another blow
March 23, 2007Research and Development
AstraZeneca seems likely to abandon another of its drug projects in what is the latest major late-stage failure to have …
European News Roundup
March 23, 2007Sales and Marketing
Datamonitor reports on the European market:Lilly withdraws EU Arxxant applicationEli Lilly has withdrawn a marketing application for diabetic retinopathy drug …
US News Roundup
March 23, 2007Sales and Marketing
Datamonitor reports on the American market:FDA grants Ranbaxy tentative approval for insomnia drugRanbaxy has received tentative approval from the FDA …
Schering acquisition boosts Bayer’s 2006 turnover figures
March 22, 2007Sales and Marketing
Bayer HealthCare's turnover rose 46% to €11.7 billion on the back of Bayer Group's acquisition of Schering last year. As …
Shire to raise Alzheimer’s awareness
March 21, 2007Medical Communications
Shire Pharmaceuticals has appointed PR and med ed firm hsdcommunications to help raise awareness of its Alzheimer's treatment Reminyl.The specialty …
BMS expands Indian biotech collaboration
March 21, 2007Research and Development BMS, India
Bristol-Myers Squibb will establish a new integrated drug development facility in Bangalore as part of an expansion of its R&D …
Servier “named and shamed” for sales slides
March 21, 2007Sales and Marketing ethics
Servier has been publicly "named and shamed" for using inappropriate materials to train its sales reps.Servier and another company, Shire …
Schering-Plough to buy Organon for 11 billion euros
March 21, 2007Sales and Marketing Merck, Schering-Plough
Schering-Plough is to buy Organon BioSciences by the end of this year, in an €11 billion cash deal.The acquisition will …
Latest content
FibroFind appoints Lee Borthwick as CEO
